NumerixS Investment Technologies’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-500
Closed -$37K 810
2020
Q2
$37K Buy
500
+300
+150% +$23.5K 0.01% 856
2020
Q1
$12K Buy
+200
New +$13.9K 0.01% 873
2019
Q3
Sell
-400
Closed -$32K 1245
2019
Q2
$32K Sell
400
-9,400
-96% -$745K 0.01% 852
2019
Q1
$816K Buy
9,800
+9,500
+3,167% +$992K 0.11% 225
2018
Q4
$34K Buy
+300
New +$34.7K 0.01% 843
2018
Q3
Sell
-700
Closed -$81K 1384
2018
Q2
$81K Sell
700
-100
-13% -$10.9K 0.02% 815
2018
Q1
$68K Buy
+800
New +$62K 0.02% 752
2017
Q4
Sell
-3,000
Closed -$173K 1368
2017
Q3
$173K Sell
3,000
-3,400
-53% -$201K 0.04% 556
2017
Q2
$410K Buy
6,400
+5,200
+433% +$320K 0.06% 398
2017
Q1
$69K Buy
+1,200
New +$71.6K 0.01% 967
2016
Q3
Sell
-10,400
Closed -$579K 1325
2016
Q2
$579K Buy
10,400
+1,400
+16% +$84.4K 0.08% 352
2016
Q1
$546K Sell
9,000
-5,400
-38% -$318K 0.06% 430
2015
Q4
$920K Buy
14,400
+9,600
+200% +$623K 0.11% 235
2015
Q3
$322K Buy
+4,800
New +$339K 0.04% 504

Other funds holding USNA

NumerixS Investment Technologies's USNA Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Usana Health Sciences (USNA) in Q3 2020, closing a stake of 500 shares — an estimated $37K sold.

NumerixS Investment Technologies first reported a position in USNA in Q3 2015 and held it in 14 quarters. The position peaked at $920K in Q4 2015. 192 funds tracked by Wall St. Rank hold USNA as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Usana Health Sciences position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 500 Usana Health Sciences shares in Q3 2020, an estimated $37K.
  • NumerixS Investment Technologies first reported a position in Usana Health Sciences in Q3 2015 and held it in 14 quarters.
  • NumerixS Investment Technologies's Usana Health Sciences position peaked at $920K in Q4 2015.
  • 192 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.